Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sernova communication.

<< Previous

Bullboard Posts

Next >>

Comment by Sailboatdreamon Apr 29, 2022 11:31am

107 Views

Post# 34642465

RE:Sernova communication.

Good observation. As more experienced investors get involved with Sernova, they will have to up their game. Institutional investors don't go for fluff... or amateur moves. They will expect results. They will be demanding. This should help everyone.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec